C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
167/210, 260/239
C07D 487/06 (2006.01) A61K 31/55 (2006.01)
Patent
CA 2010639
Novel tetahydroimidazo[1,4]benzodiazepin-2-thiones are disclosed which possess antiviral activity, and have the structure of formula (I): (see formula I) wherein R1 is C1-6alkyl, C3-6alkenyl, C3-6alkynyl, C3-6cycloalkyl, or C1-6alkyl substituted with aryl or with C3-6cycloalkyl; R2 is hydrogen or C1-6alkyl; R3 is hydrogen or C1-6alkyl; R4 and R5 each independently are hydrogen, C1-6alkyl, halo, cyano, nitro, trifluoromethyl, hydroxy, C1-6alkyloxy, amino or mono-or di(C1-6alkylamino); and aryl is phenyl optionally substituted with from 1 to 3 substituents independently selected from C1-6alkyl, halo, hydroxy, C1-6alkyloxy, amino, nitro and trifluoromethyl, or pharmaceutically acceptable acid addition salts and steriochemical isomers of Formula (I). Compositions containing these compounds as active ingredients and the use of these compounds for treating subjects suffering from viral infections are also disclosed.
Breslin Henry J.
Janssen Paul A.j.
Kukla Michael J.
Raeymaekers Alfons H.m.
Van Gelder Josephus L.h.
Gowling Lafleur Henderson Llp
Janssen Pharmaceutica Naamloze Vennootschap
LandOfFree
Antiviral tetrahydroimidazo [1,4] benzodiazepin-2-thiones does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antiviral tetrahydroimidazo [1,4] benzodiazepin-2-thiones, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antiviral tetrahydroimidazo [1,4] benzodiazepin-2-thiones will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1897969